BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28774266)

  • 1. Evolution of the p53-MDM2 pathway.
    Åberg E; Saccoccia F; Grabherr M; Ore WYJ; Jemth P; Hultqvist G
    BMC Evol Biol; 2017 Aug; 17(1):177. PubMed ID: 28774266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of MDM2 family genes.
    Momand J; Villegas A; Belyi VA
    Gene; 2011 Oct; 486(1-2):23-30. PubMed ID: 21762762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interplay between MDM2, p63/p73 and mutant p53.
    Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
    Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.
    Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW
    Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural diversity of p63 and p73 isoforms.
    Osterburg C; Dötsch V
    Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
    Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracing the evolution of the p53 tetramerization domain.
    Joerger AC; Wilcken R; Andreeva A
    Structure; 2014 Sep; 22(9):1301-1310. PubMed ID: 25185827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diversification and complex evolutionary history of the p53 tumor suppressor gene family.
    Nedelcu AM; Tan C
    Dev Genes Evol; 2007 Dec; 217(11-12):801-6. PubMed ID: 17924139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
    Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish.
    Lane DP; Madhumalar A; Lee AP; Tay BH; Verma C; Brenner S; Venkatesh B
    Cell Cycle; 2011 Dec; 10(24):4272-9. PubMed ID: 22107961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer.
    Kelley ML; Winge P; Heaney JD; Stephens RE; Farell JH; Van Beneden RJ; Reinisch CL; Lesser MP; Walker CW
    Oncogene; 2001 Feb; 20(6):748-58. PubMed ID: 11314008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.
    Åberg E; Karlsson OA; Andersson E; Jemth P
    J Phys Chem B; 2018 Jul; 122(27):6899-6905. PubMed ID: 29878773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic analysis of the p53 and p63/p73 gene families.
    Pintus SS; Fomin ES; Oshurkov IS; Ivanisenko VA
    In Silico Biol; 2007; 7(3):319-32. PubMed ID: 18415980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies raised against Xenopus p53 interact with human p73.
    Le Bras M; Delattre V; Bensaad K; Blandino G; Soussi T
    Oncogene; 2002 Feb; 21(8):1304-8. PubMed ID: 11850851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.